DDIT3 and diffuse large B-cell lymphoma: In another study, researchers concluded that miR-146a is associated with a good prognosis of DLBCL (de novo) when its expression level significantly increased in patients’ serum after chemotherapy (CHOP, R-CHOP) [41].